• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植术后贫血的患病率及相关性

Prevalence and association of post-renal transplant anemia.

作者信息

Elsayed Hesham, Sany Dawlat, Eldin Essam Nour, El-shahawy Yasser, Shawki Sahar, Aziz Ahmed

机构信息

Division of the Renal Disease, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

出版信息

Saudi J Kidney Dis Transpl. 2012 May;23(3):461-6.

PMID:22569428
Abstract

In some renal allograft recipients, anemia persists or develops following transplantation. Anemia is associated with pre-operative blood loss and allograft dysfunction, including delayed graft function, acute rejection and chronic allograft dysfunction. To study the prevalence and association of post-renal transplant anemia, we studied 200 renal transplant recipients; 131 (65.5%) patients were males and 69 (34.5%) patients were females, and age ranged from 17 to 67 years, with a mean of 37.7 ± 10.8 years. All patients were receiving cyclosporine, prednisolone and mycophenolate mofetil (MMF). Complete blood count was done at two times: three and six months post-renal transplant. There were 74% anemic patients three months after renal transplantation and 45% anemic patients six months after renal transplantation. High creatinine value, female gender, delayed graft function, episodes of acute rejection, perioperative blood loss and infections were the only significant independent risk factors for prevalence of anemia post-renal transplant. In our study, we did not find an association between MMF and cyclosporine nor angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptors blocker (ARBs) with anemia. This study demonstrates that anemia is a common complication during the first six months after kidney transplantation, with several risk factors precipitating this complication.

摘要

在一些肾移植受者中,贫血在移植后持续存在或出现。贫血与术前失血和移植肾功能障碍有关,包括移植肾功能延迟恢复、急性排斥反应和慢性移植肾功能障碍。为了研究肾移植后贫血的患病率及相关性,我们对200例肾移植受者进行了研究;其中131例(65.5%)为男性,69例(34.5%)为女性,年龄在17至67岁之间,平均年龄为37.7±10.8岁。所有患者均接受环孢素、泼尼松龙和霉酚酸酯(MMF)治疗。在肾移植后的3个月和6个月这两个时间点进行全血细胞计数。肾移植后3个月时有74%的患者贫血,6个月时有45%的患者贫血。高肌酐值、女性性别、移植肾功能延迟恢复、急性排斥反应发作、围手术期失血和感染是肾移植后贫血患病率的仅有的显著独立危险因素。在我们的研究中,我们未发现MMF与环孢素之间、血管紧张素转换酶抑制剂(ACEI)或血管紧张素受体阻滞剂(ARB)与贫血之间存在关联。本研究表明,贫血是肾移植后前6个月内的常见并发症,有多种危险因素促成了这一并发症。

相似文献

1
Prevalence and association of post-renal transplant anemia.肾移植术后贫血的患病率及相关性
Saudi J Kidney Dis Transpl. 2012 May;23(3):461-6.
2
[Incidence and management of anemia in renal transplantation: an observational-French study].肾移植中贫血的发病率及管理:一项法国观察性研究
Nephrol Ther. 2008 Dec;4(7):575-83. doi: 10.1016/j.nephro.2008.04.009. Epub 2008 Jul 30.
3
Anaemia after renal transplantation.肾移植后的贫血
Nephrol Dial Transplant. 2004 Aug;19 Suppl 5:V54-58. doi: 10.1093/ndt/gfh1057.
4
Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.慢性移植肾功能不全的肾移植受者长期移植肾失功的危险因素。
Exp Clin Transplant. 2010 Dec;8(4):277-82.
5
Prevalence of anemia in renal transplant patients: results from MOST, an observational trial.肾移植患者贫血的患病率:MOST观察性试验的结果
Transplant Proc. 2005 Nov;37(9):3821-2. doi: 10.1016/j.transproceed.2005.10.054.
6
A prospective protocol-based trial of darbepoetin alfa therapy to correct the early anemia following renal transplantation.一项基于方案的前瞻性试验,旨在使用达贝泊汀α治疗纠正肾移植后的早期贫血。
Transplant Proc. 2010 Nov;42(9):3537-41. doi: 10.1016/j.transproceed.2010.06.035.
7
Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.肾移植患者从钙调神经磷酸酶抑制剂转换为西罗莫司后出现移植肾功能障碍的长期结果。
Nephrol Dial Transplant. 2005 Nov;20(11):2517-23. doi: 10.1093/ndt/gfh957. Epub 2005 Jun 28.
8
Low prevalence of BK virus nephropathy on nonprotocol renal biopsies in Iranian kidney transplant recipients: one center's experience and review of the literature.伊朗肾移植受者非方案肾活检中BK病毒肾病的低患病率:单中心经验及文献综述
Exp Clin Transplant. 2010 Dec;8(4):297-302.
9
Anemia after kidney transplantation; its prevalence, risk factors, and independent association with graft and patient survival: a time-varying analysis.肾移植后贫血;其患病率、危险因素及与移植物和患者生存的独立相关性:时变分析。
Transplantation. 2012 May 15;93(9):923-8. doi: 10.1097/TP.0b013e31824b36fa.
10
Evolution of glomerular filtration rate, renal injury markers, anemia, and angiotensin blockers use after change from calcineurin inhibitors to sirolimus in transplant patients with neoplasia versus chronic allograft nephropathy.患有肿瘤的移植患者与慢性移植肾肾病患者从钙调神经磷酸酶抑制剂转换为西罗莫司后,肾小球滤过率、肾损伤标志物、贫血及血管紧张素阻滞剂使用情况的演变
Transplant Proc. 2011 Jul-Aug;43(6):2187-90. doi: 10.1016/j.transproceed.2011.06.055.

引用本文的文献

1
A systematic review and meta-analysis of factors contributing to post-kidney transplant anemia and the effect of erythropoietin-stimulating agents.一项系统评价和荟萃分析,探讨导致肾移植后贫血的因素以及促红细胞生成素刺激剂的影响。
Syst Rev. 2024 Nov 12;13(1):278. doi: 10.1186/s13643-024-02709-8.